M P8 Pill - yellow oval, 8mm
Pill with imprint M P8 is Yellow, Oval and has been identified as Pantoprazole Sodium Delayed Release 20 mg. It is supplied by Matrix Laboratories Limited.
Pantoprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; Duodenal Ulcer; GERD; Gastritis/Duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M P8
Pantoprazole Sodium Delayed Release
- Imprint
- M P8
- Strength
- 20 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Matrix Laboratories Limited
- National Drug Code (NDC)
- 00378-6688
- Inactive Ingredients
-
ferrosoferric oxide,
calcium stearate,
mannitol,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
propylene glycol,
sodium carbonate,
shellac,
titanium dioxide,
triethyl citrate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "M P8"
More about pantoprazole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (433)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: proton pump inhibitors
- Breastfeeding
Patient resources
- Pantoprazole drug information
- Pantoprazole (Intravenous) (Advanced Reading)
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Injection
Other brands
Professional resources
- Pantoprazole monograph
- Pantoprazole (FDA)
- Pantoprazole Granules (FDA)
- Pantoprazole Injection (FDA)
- Pantoprazole Oral Suspension (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.